Suppr超能文献

膜联蛋白 A7 通过与 Sorcin 相互作用促进上皮-间充质转化,并有助于肝癌的侵袭性。

AnnexinA7 promotes epithelial-mesenchymal transition by interacting with Sorcin and contributes to aggressiveness in hepatocellular carcinoma.

机构信息

Department of Pathology and Forensics, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.

Department of Pathology, Dalian Municipal Central Hospital affiliated with Dalian Medical University, Dalian, 116033, China.

出版信息

Cell Death Dis. 2021 Oct 29;12(11):1018. doi: 10.1038/s41419-021-04287-2.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and metastasis is the major cause of the high mortality of HCC. In this study, we identified that AnnexinA7 (ANXA7) and Sorcin (SRI) are overexpressed and interacting proteins in HCC tissues and cells. In vitro functional investigations revealed that the interaction between ANXA7 and SRI regulated epithelial-mesenchymal transition (EMT), and then affected migration, invasion, and proliferation in HCC cells. Furthermore overexpression/knockdown of ANXA7 was remarkably effective in promoting/inhibiting tumorigenicity and EMT in vivo. Altogether, our study unveiled a mechanism that ANXA7 promotes EMT by interacting with SRI and further contributes to the aggressiveness in HCC, which provides a novel potential therapeutic target for preventing recurrence and metastasis in HCC.

摘要

肝细胞癌 (HCC) 是全球最常见的癌症之一,转移是 HCC 高死亡率的主要原因。在这项研究中,我们鉴定出膜联蛋白 A7 (ANXA7) 和 Sorcin (SRI) 是 HCC 组织和细胞中过表达和相互作用的蛋白。体外功能研究表明,ANXA7 和 SRI 之间的相互作用调节上皮-间充质转化 (EMT),进而影响 HCC 细胞的迁移、侵袭和增殖。此外,过表达/敲低 ANXA7 可显著有效地促进/抑制体内肿瘤发生和 EMT。总的来说,我们的研究揭示了一种机制,即 ANXA7 通过与 SRI 相互作用促进 EMT,并进一步促进 HCC 的侵袭性,为预防 HCC 复发和转移提供了一个新的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc3/8556303/6915ff25ec37/41419_2021_4287_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验